Log In
BCIQ
Print this Print this
 

ViaDor-Calcitonin (formerly ViaDerm-Calcitonin)

  Manage Alerts
Collapse Summary General Information
Company Syneron Medical Ltd.
DescriptionCalcitonin delivered using ViaDor transdermal system
Molecular Target Calcitonin receptor
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today